Publications and Further Research Outputs
Peer-Reviewed Publications
O'Shea R, Clarke R, Berkley E, Giffney C, Farrell M, O'Donovan E, Gallagher DJ., Next generation sequencing is informing phenotype: a TP53 example., Familial cancer, 17, (1), 2018, p123-128
Saya S, Killick E, Thomas S, Taylor N, Bancroft EK, Rothwell J, Benafif S, Dias A, Mikropoulos C, Pope J, Chamberlain A, Gunapala R, SIGNIFY Study Steering Committee, Izatt L, Side L, Walker L, Tomkins S, Cook J, Barwell J, Wiles V, Limb L, Eccles D, Leach MO, Shanley S, Gilbert FJ, Hanson H, Gallagher D, Rajashanker B, Whitehouse RW, Koh DM, Sohaib SA, Evans DG, Eeles RA., Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls., Familial cancer, 16, (3), 2017, p433-440
McVeigh TP, Cody N, Carroll C, Duff M, Farrell M, Bradley L, Gallagher D, McDevitt T, Green AJ., Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series., Cancer genetics, 214-215, 2017, p1-8
McVeigh TP, Sweeney KJ, Kerin MJ, Gallagher DJ., A qualitative analysis of the attitudes of Irish patients towards participation in genetic-based research., Ir J Med Sci, 185, (4), 2016, p825-831
McVeigh TP, Duff M, Carroll C, O'Shea R, Bradley L, Farrell M, Gallagher DJ, Clabby C, Green AJ., MUTYH-Associated Polyposis: The Irish Experience>., Irish medical journal, 109, (10), 2016, p485
Gleeson J, Gallagher D., Diagnosing Lynch Syndrome., Irish medical journal, 109, (10), 2016, p487
Gogarty DS, Farrell MP, Gallagher DJ., Genetic testing and interpretive complexity: a BRCA1 gene mutation example., Ir J Med Sci, 185, (4), 2016, p955-957
Sharma S, Barry M, Gallagher DJ, Kell M, Sacchini V., An overview of triple negative breast cancer for surgical oncologists., Surgical oncology, 24, (3), 2015, p276-283
Sullivan J, Kopp R, Stratton K, Manschreck C, Corines M, Rau-Murthy R, Hayes J, Lincon A, Ashraf A, Thomas T, Schrader K, Gallagher D, Hamilton R, Scher H, Lilja H, Scardino P, Eastham J, Offit K, Vijai J, Klein RJ., An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality., British journal of cancer, 113, (1), 2015, p166-172
Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mæhle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A, Skytte AB, Lam J, Taylor L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Blanco I, Salinas M, Cook J, Rosario DJ, Buys S, Conner T, Ausems MG, Ong KR, Hoffman J, Domchek S, Powers J, Teixeira MR, Maia S, Foulkes WD, Taherian N, Ruijs M, Helderman-van den Enden AT, Izatt L, Davidson R, Adank MA, Walker L, Schmutzler R, Tucker K, Kirk J, Hodgson S, Harris M, Douglas F, Lindeman GJ, Zgajnar J, Tischkowitz M, Clowes VE, Susman R, Ramón y Cajal T, Patcher N, Gadea N, Spigelman A, van Os T, Liljegren A, Side L, Brewer C, Brady AF, Donaldson A, Stefansdottir V, Friedman E, Chen-Shtoyerman R, Amor DJ, Copakova L, Barwell J, Giri VN, Murthy V, Nicolai N, Teo SH, Greenhalgh L, Strom S, Henderson A, McGrath J, Gallagher D, Aaronson N, Ardern-Jones A, Bangma C, Dearnaley D, Costello P, Eyfjord J, Rothwell J, Falconer A, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Kote-Jarai Z, Lubinski J, Axcrona U, Melia J, McKinley J, Mitra AV, Moynihan C, Rennert G, Suri M, Wilson P, Killick E, IMPACT Collaborators, Moss S, Eeles RA., Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study., European urology, 66, (3), 2014, p489-499
Gallagher DJ, Vijai J, Hamilton RJ, Ostrovnaya I, Iyer G, Garcia-Grossman IR, Kim PH, Przybylo JA, Alanee S, Riches JC, Regazzi AM, Milowsky MI, Offit K, Bajorin DF., Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host., Annals of oncology : official journal of the European Society for Medical Oncology, 24, (9), 2013, p2414-2421
Farrell MP, Hughes DJ, Drost M, Wallace AJ, Cummins RJ, Fletcher TA, Meany MA, Kay EW, de Wind N, Power DG, Andrews EJ, Green AJ, Gallagher DJ., Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity., Familial cancer, 12, (4), 2013, p741-747
Bambury RM, Gallagher DJ., Prostate cancer: germline prediction for a commonly variable malignancy., BJU international, 110, (11 pt c), 2012, pE809-18
Gallagher DJ, Cronin AM, Milowsky MI, Morris MJ, Bhatia J, Scardino PT, Eastham JA, Offit K, Robson ME., Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer., BJU international, 109, (5), 2012, p713-719
Gallagher DJ, Al-Ahmadie H, Ostrovnaya I, Gerst SR, Regazzi A, Garcia-Grossman I, Riches J, Gounder SK, Flaherty AM, Trout A, Milowsky MI, Bajorin DF., Sunitinib in urothelial cancer: clinical, pharmacokinetic, and immunohistochemical study of predictors of response., European urology, 60, (2), 2011, p344-349
Gallagher DJ, Konner JA, Bell-McGuinn KM, Bhatia J, Sabbatini P, Aghajanian CA, Offit K, Barakat RR, Spriggs DR, Kauff ND., Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity., Annals of oncology : official journal of the European Society for Medical Oncology, 22, (5), 2011, p1127-1132
Tickoo SK, Milowsky MI, Dhar N, Dudas ME, Gallagher DJ, Al-Ahmadie H, Gopalan A, Fine SW, Ishill N, Bajorin DF, Reuter VE., Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications., BJU international, 107, (5), 2011, p844-849
Gallagher DJ, Feifer A, Coleman JA., Genitourinary cancer predisposition syndromes., Hematology/oncology clinics of North America, 24, (5), 2010, p861-883
Gallagher DJ, Gaudet MM, Pal P, Kirchhoff T, Balistreri L, Vora K, Bhatia J, Stadler Z, Fine SW, Reuter V, Zelefsky M, Morris MJ, Scher HI, Klein RJ, Norton L, Eastham JA, Scardino PT, Robson ME, Offit K., Germline BRCA mutations denote a clinicopathologic subset of prostate cancer., Clinical cancer research : an official journal of the American Association for Cancer Research, 16, (7), 2010, p2115-2121
Gallagher DJ, Smith JD, Offit K, Stadler ZK., Diagnosing hereditary colorectal cancer., Clinical colorectal cancer, 9, (4), 2010, p205-211
Stadler ZK, Gallagher DJ, Thom P, Offit K., Genome-wide association studies of cancer: principles and potential utility., Oncology (Williston Park, N.Y.), 24, (7), 2010, p629-637
Gallagher DJ, Kemeny N., Metastatic colorectal cancer: from improved survival to potential cure., Oncology, 78, (3-4), 2010, p237-248
Gallagher DJ, Vijai J, Cronin AM, Bhatia J, Vickers AJ, Gaudet MM, Fine S, Reuter V, Scher HI, Halldén C, Dutra-Clarke A, Klein RJ, Scardino PT, Eastham JA, Lilja H, Kirchhoff T, Offit K., Susceptibility loci associated with prostate cancer progression and mortality., Clinical cancer research : an official journal of the American Association for Cancer Research, 16, (10), 2010, p2819-2832
Gallagher DJ, Riches J, Bajorin DF., False elevation of human chorionic gonadotropin in a patient with testicular cancer., Nature reviews. Urology, 7, (4), 2010, p230-233
Gallagher DJ, Milowsky MI, Gerst SR, Ishill N, Riches J, Regazzi A, Boyle MG, Trout A, Flaherty AM, Bajorin DF., Phase II study of sunitinib in patients with metastatic urothelial cancer., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28, (8), 2010, p1373-1379
Gallagher DJ, Kemeny N., Improving response and outcomes for patients with liver-limited metastatic colorectal cancer., Clinical colorectal cancer, 9 Suppl 1, 2010, pS36-43
Gallagher DJ, Milowsky MI, Iasonos A, Maluf FC, Russo P, Dalbagni G, Donat MS, Boyle MG, Zheng J, Riches J, Bajorin DF., Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma., Cancer, 115, (22), 2009, p5193-5201
Gallagher DJ, Milowsky MI, Ishill N, Trout A, Boyle MG, Riches J, Fleisher M, Bajorin DF., Detection of circulating tumor cells in patients with urothelial cancer., Annals of oncology : official journal of the European Society for Medical Oncology, 20, (2), 2009, p305-308
Gallagher DJ, Libby DM, Kemeny N., Elevated carcinoembryonic antigen and sarcoidosis masquerading as metastatic colon cancer., Clinical colorectal cancer, 8, (3), 2009, p172-174
Gallagher DJ, Kemeny NE., Colorectal hepatic metastases: adjuvant chemotherapy and survival., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27, (20), 2009, pe18-9; author reply e20-1
Gallagher D, Kemeny N., Treatment of patients with colorectal cancer: emphasis on liver metastases., Expert opinion on pharmacotherapy, 10, (1), 2009, p109-124
Gallagher DJ, Zheng J, Capanu M, Haviland D, Paty P, Dematteo RP, D'Angelica M, Fong Y, Jarnagin WR, Allen PJ, Kemeny N., Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases., Annals of surgical oncology, 16, (7), 2009, p1844-1851
Gallagher DJ, Milowsky MI, Bajorin DF., Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting., Cancer, 113, (6), 2008, p1284-1293
Gallagher DJ, Kemeny N., Second-line management of metastatic colorectal cancer., Clinical colorectal cancer, 7, (1), 2008, p25-32
Management of mutation negative patients in, Hereditary Gynecological Cancer: Risk, Prevention, and Management, 2008, [Gallagher DJ, Kauff N.]
Gallagher DJ, Bajorin DF., Neoadjuvant chemotherapy for the treatment of muscle-invasive bladder cancer: argument in favor., Nature clinical practice. Urology, 5, (9), 2008, p484-485
Gallagher DJ, Duffy A, McCaffrey J., Wilms' tumour in adults: a case report and review of the literature., Ir J Med Sci, 176, (1), 2007, p49-51
Gallagher DJ, Capanu M, Raggio G, Kemeny N., Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis., Annals of oncology : official journal of the European Society for Medical Oncology, 18, (12), 2007, p1995-1999
Recognition
Representations
National Cancer Control Programme Executive Committee
Bobby Bastow Cancer Genetics Foundation Chair
Reviewer for New England Journal of Medicine
Reviewer for Journal of Clinical Oncology
Awards and Honours
. ASCO/AACR/FECS Methods in Clinical Cancer Research Workshop (My registrar)
American Society of Clinical Oncology Merit Award Annual Meeting
American Society of Clinical Oncology Merit Award Genitourinary Symposium
American Society of Clinical Oncology Merit Award Gastrointestinal Symposium
American Association of Cancer Research Molecular Biology Workshop
Broad Insititute Genetics of Complex Disorders Workshop
Goldstein Award MSKCC Prevention and Population Research - $50,000
. ASCO/AACR/FECS Methods in Clinical Cancer Research Workshop
. Irish Society of Medical Oncology Scholarship to MSKCC
. University College Dublin Scholarship to University of Pennsylvania
Memberships
FRCPI
Irish Society of Medical Oncology
Cancer Trials Ireland
American Society of Clinincal Oncology
European Society of Medical Oncology
PRACTICAL: The PRostate cancer AssoCiation Group To Investigate Cancer Associated aLterations in the genome
COGS: The Collaborative Ovarian, prostate, and breast Gene environment Study
CIMBA BRCA1/2 mutation carrier consortium